Carles Galdeano has participated in the identification of a new therapeutic target for diseases caused by lack of oxygen. This work has been recently published in the journal Nature Communications (http://www.nature.com/articles/ncomms13312).

Link to the UB press release: http://www.ub.edu/web/ub/en/menu_eines/noticies/2016/11/027.html

Link to the press: http://www.lavanguardia.com/vida/20161115/411882366948/crean-una-molecula-para-tratar-enfermedades-causadas-por-la-falta-de-oxigeno.html